Priya N. Werahera, PhD, presented “TRUS Biopsy, MRI, and PROMIS Trial” during the 29th Annual International Prostate Cancer Update on January 26, 2019 in Beaver Creek, Colorado.
How to cite: Werahera, Priya N. “TRUS Biopsy, MRI, and PROMIS Trial”. January 26, 2019. Accessed Aug 2022. https://grandroundsinurology.com/trus-biopsy-mri-and-promis-trial/
TRUS Biopsy, MRI, and PROMIS Trial
Priya N. Werahera, PhD, discusses the PROstate MR Imaging Study (PROMIS) trial and its implications for use in prostate cancer screening.
Priya N. Werahera, PhD, discusses the PROstate MR Imaging Study (PROMIS) trial, which investigated whether multi-parametric (MP)-MRI can discriminate between men with and without clinically-significant prostate cancer who are at risk prior to first biopsy. Results showed mpMRI performed better than expected in a multicenter setting when used across 11 centers and by over a dozen radiologists. Dr. Werahera also discusses several limitations of the PROMIS trial as well as assessing the utility of biomarkers to identify men with clinically significant prostate cancer.
About the International Prostate Cancer Update
The International Prostate Cancer Update (IPCU) is an annual, multi-day CME conference focused on prostate cancer treatment updates. The conference’s faculty consists of international experts, and the event caters to urologists, medical oncologists, radiation oncologists, and other healthcare professionals. Topics encompass prostate cancer management, from diagnosis to treating advanced and metastatic disease. Dr. Werahera presented this lecture during the 29th IPCU in 2019. Please visit this page in order to learn more about future IPCU meetings.